The mortality and morbidity of newborns with low birth-weight are considerably higher than in newborns with normal body-weight. The incidence of perinatal death and injury is highest in the low birth-weight group. In countries with low prematurity rates perinatal mortality is in most cases correspondingly low, e. g. Sweden and the Netherlands. Hence the most pressing task of obstetrical and perinatal medicine is to lower the number of newborns with low birth-weight to the minimum. PAPIERNIK [10] and our staflf [12] have developed independently programs which can be used for evaluating in advance the risk of low birth-weight, so that appropriate measures can be taken in time.
Development of our program
The program was started in 1971. We selected pregnant women at risk using a list of 36 risk factors. These factors were chosen on the basis of published data and our own clinical experience [2, 3, 5, 6, 7, 13, 15, 16] . They were separated into factor groups: nontreatable factors or factors of persisting risk after treatment (e. g. previous abortions or uterine bleeding early in gestation) and treatable or removable factors (e. g. smoking or development of gestosis). We also determined whether the presence of the individual factor increases the risk of prematurity, dysmaturity or both. Since there were no exact data available on the relative validity of each factor they were first Curriculum vitae JÖRG MICHAEL GIFFEI was born in 1942 in Königshofen (Bavaria) registered in a PDP-list I [12] , each factor having equal validity. This was known to be unsatisfactory but unavoidable if a Start was to be made.
The list was filled in during the first examination of the pregnant woman at the clinic and supplemented äs required during later visits. If more than 2 risk factors indicated possible premature labor or 2 or more factors possible dysmaturity, the patient was given special prenatal care, described in more detail below. A year later we evaluated our material. One of the first consequences was to change PDP-list I. Instead of using factors of equal validity, each factor was assigned a certain number of points. This was an attempt to evaluate individual factor more precisely. PDP-list II resulted from this procedure (Fig. 1 We realize that this System may require further changes, äs the greater number of patients observed according to this program will allow a better evaluation of factor validity. In addition, our list is mainly concerned with the Situation in central Europe. Modifications will be required for countries with different types of population and socio-economic structures.
Results related to the degree of risk
The point System of PDP-list II was retrospectively applied to PDP-list I in order to ascertain the lowest number of points indicating real success with the yet relatively inexact selection Thus during the initial consultation we perform a list L vaginal examination and we repeat this every 2 The second year (Tab. I below) using PDP-list II, to 4 weeks, if not more f requently äs indicated the incidence of newborns with low birth*· weight was decreased by 3.6% in Group III äs compared with Group II (p < 0.01), a reduction of more than 35% in the number of infants with a birth-weight of 2500 g or less.
Tab. II shows the further differentiation of Group III from Tab. I, providing the following inter-(e. g. by increased uterine activity). A point System is of value for recörding cervical finding (Fig. 4) . The early diägnosis of cervical incompetency is possible and operative therapy f cervical suturej can be applied. Uterine contractions must be observed in this manner so that when the cervix becomes shorter esting results: Section B according to PDP-list I and/or the cervical canal opens, tocolytic therapy (risk unsuspected) shows a still relatively high with beta-mimetic drugs can be performed. incidence of 5.7% of low birth-weight infants. The second year this figure was decreased to 1.6% using List II. This demonstrates the value of the improved point System. The
Tocolytic therapy
We are successfülly using outpatient tocolytic decrease from 5.7% to 1.6% is statistically sig-therapy at very early stages of increased nificant (p < 0.005).
uterine activity, äs we recommended in 1971 [12].
Practical procedures
As SU g ge sted by SCHWALM, cited by MOSLER [9], The outpatient clinic for this special purpose is we consider more than 10 contractions, or more organized differently than that for other patients. than 5 per day lasting longer than 40 seconds Whenever possible the same physician attends to as pathological (increased) uterine activity and the same patient thus ensuring continuity, better therefore as an indication for oral therapy with super vision and treatment of individuals.
beta-mimetic drugs. Unfortunätely there are More time is required for such consultation, st ill no additional objective indications for since the patient is questioned more intensively likewisely early therapy since there are no data on and problems are explained to her more exactly. the borderline between the physiological and Thus she can, for instance, determine increased pathological rate and durätion of contractions, uterine activity herseif and record the frequency particularly in the everyday environment of the and durätion of contractions. patient. .
We are using Th 1165a (Partusisten®; BOEH-3.1 Special examinations and therapy RINGE^ i nge lheim) combined if needed with In addition, special examinations are performed Verapamil (Isoptin®; KNOLL AG). The latter routinely at certain intervals.
inhibits the side-eifects of Th 1165a on the Fig. 4 . Point System for evaluating the cervical finding in respect to the risk of prematurity.
maternal heart ("palpitation"). Our tablets contain 2.5 mg Th 1165a. The usual dose is 6 1/2 a tablet daily, taken at intervals of no more than 4 hours. I£ necessary the dose may be increased without risk to 6 tablets daily. (True premature labor of course must be treated by intravenous infusions of Th 1165 a.) give up to 6 5 mg daily, which may, however, lower the subjective wellbeeing o£ the patient considerably. One Isoptin retard dragee contains 120mg Isoptin-hydrochloride. Depending on the dose of Th 1165 a up to 3 dragees a day are administered. Numerous data are available on the side-effects of beta mimetic substances taken over prolonged periods [11, 17] . Serious härm to mother or fetus has not been noted.
3.1.2 Further important measures to prevent premature labor These include recommendation of work stoppage or, if the risk is high, of bed rest. In addiiion, the character of the risk factors has many possible consequences. Exact descriptions are not required here since it is well known that e. g. gestosis (toxemia) or an infection during pregnancy must be treated adequately.
Management of the risk of dysmaturity
In patients with dysmaturity risk, fetal growth should be monitored with ultrasound. Determination of the biparietal head diameter alone is not completely adequate. If, however, the transversal thorax diameter is taken äs an additional measure of the fetus, a more precise determination of fetal size is obtained. We use the nomogram published by HANSMANN and VOIGT (Fig. 5, left top) which enables us to estimate body-weight more accurately. According to the author, the deviation f rom the actual weight is less than 10% in 80% of all cases. Fetal measurements are taken, depending on the individual case, at 2 to 4 week intervals so that an increasing deviation from the norm can be seen in time. The diagnosis of dysmaturity becomes more probable if other findings confirm a nutritive placental insufficiency. We use HPL s the main indicator. Urinary estrogen determinations are used to a lesser extent. In order to diagnose the additional respiratory insuf ficiency of the placenta f requently occurring in later stages o£ pregnancy, amniocentesis or amnioscopy together with cardiotocography are perf ormed.
The most important therapeutic measure in intrauterine malnutrition is bed rest. All other measures, e. g. heparin therapy [l, 8] , tocolysis or other drug treatment to improve uterine blood flow and supply of amino acids into amniotic cavity s we have proposed [4, 14] have not been tested sufficiently to recommend them for routine clinical use.
Conclusion
Realisation of the PDP-program requires considerable stafF and equipment expense. However, a clear decrease in the frequency of low birth-weight infants has already been achieved during the short time this program has been in effect.
Summary
The majority of perinatal deaths and injuries occur in cases of low birth-weight (2500 g and less). Hence obstetrical and perinatal medicine is urgently pressed to decrease the number of low birth-weight newborns. We started our PDP-program in 1971. It is based on the PDP-list filled in during the first consultation with the pregnant woman and supplemented during further examinations. The list contains 36 tisk factors separated into two factot groups: non-treatable factors or factors of persisting risk after treatment and treatable or removable factors.
All risk factors are differentiated according to their significance for pre-or dysmaturity. The first year PDP-list I gave equal validity to all factors. The second year, factors were weighed according to a point System expressed in PDP-list II (Fig. 1) . From 6 points the prematurity risk and less distinctly also the dysmaturity risk mcrease unequivocally (Figs.  2 and 3) . About 40% of all patients showed this number of points and were supervised in a special prenatal-care clinic. Tab. l summarizes results obtained in the first two years. The first year (Tab. I above) only 30% of all pregnancies could be checked using the PDP-list due to the expense of additional staff, the second year we covered 50% (Tab. I below). In Group III there were 1.9% fewer low birth-weight infants than in Group II which was not thus examined. The second year this difference reached 3.6%. This represents a total reduction in the number of infants with low birth-weight by more than 35% (significant for p < 0.01). In Tab. II Group III of Tab. I is further differentiated. The first year the incidence of 5.7% low birth-weight infants in Section B (not at risk according to PDP-list I) was still too high. Using PDP-list II in the second year the percentage was decreased to 1.6%. This decrease is significant for p < 0.005 and demonstrates the better selection due to the point System of PDP-list II. The PDP outpatient-care differs from other prenatal-care äs follows:
1. Whenever possible, the patient is always examined by the same doctor. This ensures better treatment and a continuity in medical findings. 2. More time per patient for questioning, Information and examinations usually not performed to such an extent. 3. Vaginal examinations every 2 to 4 weeks, if not more frequently äs indicated. Recording the cervical finding (Fig. 4) . 4. Outpatient tocolysis with beta-mimetic drugs at very early stages of increased uterine activity; this means: more than 10 contractions/day or more than 5/day lasting longer than 40 sec. Dosage: Partusisten® (Th 1165a), 6 X 1.25 mg/day up to 6 X 2.5 mg/day, combined if needed with Isoptin® retard (Verapamil), depending on the extent of side-effects up to 3 X 120 mg/ day. 5. Control of fetal growth by ultrasound cephalo-thoracometry every 2 to 4 weeks (Fig. 5) . If the curve so indicates, HPL determinations to diagnose nutritive placental insufficiency. 6. In late pregnancy amnioscopy and cardiotocography to determine respiratory placental insufficiency.
Realisation of the PDP-program requires considerable staff and equipment. However, a clear decrease in the frequency of low birth-weight newborns has already been achieved during the short time the program has been in efFect.
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Zusammenfassung Erste Erfahrungen und Ergebnisse mit unserem Prämaturitäts-und Dysmaturitäts-Präventions-Programm (PDP-Programm)
Der Hauptanteil der perinatal verstorbenen oder geschädigten Kinder entstammt dem Kollektiv der Neugeborenen mit niedrigem Geburtsgewicht (< 2500 g (Fig. 1) .
Ein eindeutiges Prämaturitätsrisiko besteht ab 6 Punkten aufwärts (Fig. 2) , ein Dysmaturitätsrisiko nicht ganz so deutlich ebenfalls ab 6 Punkten (Fig. 3) (Fig. 4) 
Resume Premiers resultats et experiences de notre Programme v de Prevention de Prematurite et de Dysmaturite (Programme PDP)
La majorite des enfants morts ou souffrant de lesions en periode perinatale figurent dans le groupe des nouveaux-nes dont le poids ä la naissance est au-dessous de la norme (< 2500 g). La medecine obstetrique et perinatale devra donc s'efforcer de reduire le nombre des enfants de ce groupe. C'est en 1971 que nous avons commence l'application de notre Programme PDP centre sur la Liste PDP qui est etablie a la premiere consultation de grossesse et completee aux visites ulterieures. La Liste comporte un catalogue de 36 facteurs de risque, divises graphiquement en dits »facteurs fixes« (dont la charge n'est plus corrigible) et en facteurs corrigibles ou traitables, avec differenciation egalement selon leur degre d'importance relatif au risque de prematurite ou de dysmaturite. La premiere annee d'application, la Liste PDP I juxtaposait les facteurs sans hierarchie des valeurs. La deuxieme annee et apres evaluation des resultats, on a tente d'ordonner par degre d'importance les divers facteurs selon un Systeme de points: la Liste PDP II (Fig. 1) . Un risque precis prematurite existe ä partir de 6 points et audessus (Fig. 2) , un risque de dysmaturite ä partir de 6 points (Fig. 3) . Environ 40 pour cent des femmes enceintes atteignirent chez nous ce nombre de points et elles furent suivies dans une consultation speciale, instituee a leur intention. Les resultats des deux premieres annees figurent au Tab. I. La premiere annee (partie super ieure de Tab. I) nous n'avons pu enregistrer que t out juste 30 pour cent des femmes enceintes sur la Liste PDP ä cause du travail supplementaire que cela demandait. On compta dans ce Groupe III 1,9% de moins d'enfants avec insuffisance de poids que dans le Groupe II non recense. La deuxieme annee (partie inferieure du Tab. I), cette difference atteignit 3,6%, ce qui represente une diminution globale des enfants de poids insuffisant superieure ä 35% (statistiquement significatif avec p < 0,01).
Le Tab. II resume une differenciation plus detaillee et precise du Groupe III du Tab. I. La premiere annee, le pourcentage des enfants de poids insuffisant du Groupe B (considere d'apres la Liste PDP I comme «non en danger») etait de 5,7%, soit encore trop eleve. Grace ä Tapplication de la Liste PDP II la deuxieme annee, le pourcentage de ces enfants du Groupe B a pu etre abaisse a 1,6%. La baisse est, avec p < 0,005, statistiquement significative et prouve Famelioration de la selection par le Systeme de points de la Liste II. La consultation PDP se distingue chez nous des autres consultations de clinique par les diverses reglementations suivantes: 1. Observation de la patiente toujours par le meine medecin pour garantir un examen global meilleur et plus continu de chaque cas particulier. 2. Temps plus long consacre a chaque patiente pour la consultation et les examens qui, normalernent, ne peuvent pas etre pratiques ä la meme echelie. 3. Examens vaginaux toutes les 2-4 semaines, ou meme plus souvent si cela s'avere necessaire, avec rapport du resultat cervical (Fig. 4) .
